Kyung Hee University’s Campus Town Business Unit, led by President Han Guntai, announced that on the past Friday, the 14th, they hosted the ‘CampaVision’ Demo Day through a live broadcast on YouTube at the Dance Department Building on the Seoul Campus.

During this Demo Day, nine exceptional startups nurtured by the Business Unit participated. These resident startups presented their business ideas, progress updates, and growth potential. Accelerator representatives and venture capital professionals were on-site to evaluate these aspects.

The panel of judges included Huh Yoonseok, Director of Daesung Startup Investment Co., Ltd., Yang Kyungjoon, CEO of Crypton Co., Ltd., Go Yeongha, Chairman of the Korea Association of Angel Investors, Cho Myeongwoo, CEO of Bain Ventures Co., Ltd., and Choi Gyeonghee, Partner at Sopoong Ventures Co., Ltd.

The judges assessed the originality of the startup ideas, the feasibility of their execution and potential for growth, market viability in terms of revenue, and the presentation skills of the participants. The event unfolded with team presentations followed by interactive question and answer sessions.

Among the participating resident startups were MindsGround (CEO Min Hwangi), Merlin’s Beard (CEO Kim Byungsoo), Bevery Wear (CEO Yang Hyeri), Kiwi Studio (CEO Park Cheonmyeong), Danpoonggori (CEO Kim Beomseok), Panacura (CEO Jang Hyeongjin), Lynk Solutec (CEO Seo Jeongmok), Umtul (CEO Park Seongryul), and EdmicBio (CEO Ha Dongheon).

The grand prize was awarded to Kiwi Studio, while Lynk Solutec Co., Ltd. received the top honor, and Panacura Co., Ltd. and EdmicBio Co., Ltd. were recognized with excellence awards.

Lynk Solutec, the recipient of the top honor, is a subsidiary of Yonsei University’s technology holding company. Leveraging their nano-thin film coating technology designed to prevent the attachment of blood, viruses, and bacteria, they are pioneering the development of safe and swift medical devices for patient treatment. Presently, they are focused on the development of an endoscopic cap to prevent fogging and blood attachment, crucial for maintaining a clear endoscopic view.

Over the past two years, the Business Unit has organized two startup competitions, selecting 69 teams, providing approximately 480 million KRW in startup support funds and prize money. The resident startups have attracted around 8 billion KRW in investments across 8 projects and secured approximately 4 billion KRW in government support for 87 projects.

Generating approximately 2.6 billion KRW in revenue, the startups have significantly contributed to activating the local economy of Dongdaemun-gu. The Business Unit’s commitment continues, aiming to provide tailored support to young entrepreneurs, leveraging the capabilities of the university and the local community.

[Reported by Beta News Journalist Kang Gyusoo]

Lynk Solutec, a startup specializing in cutting-edge medical solutions, has recently undertaken research into an innovative coating technology designed to proactively prevent the attachment of various substances to lenses used in endoscopic surgeries. Established by Lee Yeon-Taek (28), who collaborated closely with medical professionals at the Bio-Surface and Sensor Systems Laboratory, the company is targeting the persistent issues encountered during endoscopic procedures.

Throughout endoscopic surgeries, lenses frequently become obstructed due to factors such as patient respiration and bleeding resulting from tissue resection. Conventional methods to alleviate these problems involve integrating saline solution injection devices with the endoscope or utilizing anti-fog agents. Nevertheless, these approaches have limitations, including the potential inhalation of saline solution during airway surgeries and the inability of anti-fog agents to prevent blood adhesion.

In response, the founder of Lynksolutec embarked on a research endeavor to create a novel solution that fundamentally prevents the attachment of substances, thereby addressing lens obstructions. The outcome was the development of a nano-thin film coating with the capability to prevent the adhesion of various substances. The startup is currently in the process of producing a prototype of this technology in a user-friendly cap form suitable for endoscopic applications.

Lynk Solutec’s competitive edge is derived from its strong connection to real-world demands. With a team proficient in research and development, production, and clinical verification, the company is well-equipped to compete effectively. Notably, this collaboration includes the involvement of Kwon Hyuk-Ho, a researcher from precision injection molding company D-PharmTech, responsible for endoscope cap production, and Professor Seo Jung-Mok from Yonsei University, responsible for research and development.

The active participation of medical professionals in the startup’s research and development adds to its market potential. The founder stated, “Products related to medical devices prioritize safety and reliability due to their nature. This leads to the continued use of conventional methods and products.” Additionally, Lynk Solutec intends to collaborate with advanced hospitals that have been engaged since the early stages of development and then expand its target market to include private hospitals.

One of the challenges faced by the founder post-launch was the lack of expertise in areas such as accounting and legal matters. Notably, the mentoring provided by Yonsei University’s Startup Support Center significantly benefited the company, particularly in areas such as tax-related legal knowledge. Lynk Solutec’s potential has been recognized through its selection for the Preliminary Startup Package and Leading University Projects for Laboratory Startups.

Looking ahead, Lee Yeon-Taek envisions broadening the applications of the nano-thin film coating through further research and development. He highlighted that Lynksolutec’s coating technology can inhibit not only fogging and blood adhesion but also the attachment of proteins and bacteria, making it applicable to various medical devices such as prosthetics coatings and blood collection tubes. He expressed the company’s aspiration, saying, “Our aim is to provide both medical professionals and patients with an enhanced healthcare environment by offering products that facilitate safe and efficient surgeries.”

[Source: Hankyung Job N Joy, Reporter Jo Soo-Bin]